Basil Superspeciality Care Comprehensive Company Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-06-2024
- Paid Up Capital ₹ 0.50 M
as on 17-06-2024
- Company Age 3 years 5 months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.23 M
as on 17-06-2024
- Revenue 1360.19%
FY 2023
- Profit 203.53%
FY 2023
- Ebitda 279.06%
FY 2023
- Net Worth 140.92%
FY 2023
- Total Assets 55.35%
FY 2023
About Basil Superspeciality Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The Corporate currently has active open charges totaling ₹9.23 M.
Anish Thakur, Akash Singh, Rakesh Tirmale, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85300MH2021PTC359521
- Company No.
359521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Basil Superspeciality Care?
Board Members(5)
Financial Performance and Corporate Structure Insights of Basil Superspeciality Care.
Basil Superspeciality Care Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1360.19% increase. The company also saw a substantial improvement in profitability, with a 203.53% increase in profit. The company's net worth Soared by an impressive increase of 140.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| FY 2022 | FY 2021 | FY 2020 | FY 2019 | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Basil Superspeciality Care?
In 2023, Basil Superspeciality Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chatvaari Medical Llp
Active
1 year 1 month Anish Thakur, Rakesh Tirmale and 1 more are mutual person
Lions Aastha Hospital Private Limited
Active 1 year 1 month Anish Thakur and Akash Singh are mutual person
Family Clinique Superspeciality Hospital Private Limited
Active 2 years 11 months Rakesh Tirmale and Dhammdeep Humane are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 May 2023 | ₹9.23 M | Open |
How Many Employees Work at Basil Superspeciality Care?
Basil Superspeciality Care has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Basil Superspeciality Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Basil Superspeciality Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
